136 related articles for article (PubMed ID: 2189258)
41. Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins.
Haglund K; Leiner I; Kerksiek K; Buonocore L; Pamer E; Rose JK
J Virol; 2002 Aug; 76(15):7506-17. PubMed ID: 12097563
[TBL] [Abstract][Full Text] [Related]
42. Response of monkeys to vaccination with recombinant vaccinia virus which coexpress HIV gp160 and human interleukin-2.
Ruby J; Brinkman C; Jones S; Ramshaw I
Immunol Cell Biol; 1990 Apr; 68 ( Pt 2)():113-7. PubMed ID: 2200748
[TBL] [Abstract][Full Text] [Related]
43. Highly attenuated HTLV type Ienv poxvirus vaccines induce protection against a cell-associated HTLV type I challenge in rabbits.
Franchini G; Tartaglia J; Markham P; Benson J; Fullen J; Wills M; Arp J; Dekaban G; Paoletti E; Gallo RC
AIDS Res Hum Retroviruses; 1995 Feb; 11(2):307-13. PubMed ID: 7742044
[TBL] [Abstract][Full Text] [Related]
44. Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.
Li M; Li ZN; Yao Q; Yang C; Steinhauer DA; Compans RW
J Virol; 2006 Jun; 80(12):6106-14. PubMed ID: 16731949
[TBL] [Abstract][Full Text] [Related]
45. A macrophage fusion assay for rapid screening of cloned HIV-1 Env using dual recombinant vaccinia viruses expressing distinct RNA polymerases.
Isaacs SN; Yi Y; Singh A; Collman RG
J Virol Methods; 1999 Aug; 81(1-2):55-61. PubMed ID: 10488761
[TBL] [Abstract][Full Text] [Related]
46. HTLV-I env protein acts as a major antigen in patients with HTLV-I-associated arthropathy.
Kato T; Asahara H; Kurokawa MS; Fujisawa K; Hasunuma T; Inoue H; Tsuda M; Takahashi S; Motokawa S; Sumida T; Nishioka K
Clin Rheumatol; 2004 Oct; 23(5):400-9. PubMed ID: 15459812
[TBL] [Abstract][Full Text] [Related]
47. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response.
Coupar BE; Andrew ME; Both GW; Boyle DB
Eur J Immunol; 1986 Dec; 16(12):1479-87. PubMed ID: 3493144
[TBL] [Abstract][Full Text] [Related]
48. The induction of cytotoxic T-lymphocyte precursor cells by recombinant vaccinia virus expressing human papillomavirus type 16 L1.
Zhou JA; McIndoe A; Davies H; Sun XY; Crawford L
Virology; 1991 Mar; 181(1):203-10. PubMed ID: 1847256
[TBL] [Abstract][Full Text] [Related]
49. Analysis of alternatively spliced human immunodeficiency virus type-1 mRNA species, one of which encodes a novel tat-env fusion protein.
Furtado MR; Balachandran R; Gupta P; Wolinsky SM
Virology; 1991 Nov; 185(1):258-70. PubMed ID: 1926777
[TBL] [Abstract][Full Text] [Related]
50. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
[TBL] [Abstract][Full Text] [Related]
51. Immunization with plasmid DNA expressing the caprine arthritis-encephalitis virus envelope gene: quantitative and qualitative aspects of antibody response to viral surface glycoprotein.
Beyer JC; Chebloune Y; Mselli-Lakhal L; Hötzel I; Kumpula-McWhirter N; Cheevers WP
Vaccine; 2001 Feb; 19(13-14):1643-51. PubMed ID: 11166887
[TBL] [Abstract][Full Text] [Related]
52. Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediated by nitric oxide.
Gherardi MM; Ramírez JC; Esteban M
J Virol; 2000 Jul; 74(14):6278-86. PubMed ID: 10864637
[TBL] [Abstract][Full Text] [Related]
53. Humoral responses to the immunodominant gag and env epitopes of human T-lymphotropic virus type I among Melanesians.
Lal RB; Rudolph DL; Nerurkar VR; Yanagihara R
Viral Immunol; 1992; 5(4):265-72. PubMed ID: 1282011
[TBL] [Abstract][Full Text] [Related]
54. Identification of viral membrane proteins required for cell fusion and viral dissemination that are modified during vaccinia virus persistence.
Ortiz MA; Paez E
Virology; 1994 Jan; 198(1):155-68. PubMed ID: 8259650
[TBL] [Abstract][Full Text] [Related]
55. Generation of hybrid genes and proteins by vaccinia virus-mediated recombination: application to human immunodeficiency virus type 1 env.
Gritz L; Destree A; Cormier N; Day E; Stallard V; Caiazzo T; Mazzara G; Panicali D
J Virol; 1990 Dec; 64(12):5948-57. PubMed ID: 2243381
[TBL] [Abstract][Full Text] [Related]
56. Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin.
Panicali D; Davis SW; Weinberg RL; Paoletti E
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5364-8. PubMed ID: 6310573
[TBL] [Abstract][Full Text] [Related]
57. Immunisation of macaques with SIV env recombinants: specificity of T cell and antibody responses and evaluation of protective efficacy.
Mills KH; Page M; Kitchin P; Chan L; Jones W; Silvera P; Corcoran T; Flanagan B; Ling C; Thiriart C
J Med Primatol; 1993; 22(2-3):104-9. PubMed ID: 8411102
[TBL] [Abstract][Full Text] [Related]
58. Immune response to recombinant visna virus Gag and Env precursor proteins synthesized in insect cells.
Rafnar B; Tobin GJ; Nagashima K; Gonda MA; Gunnarsson E; Andrésson OS; Georgsson G; Torsteinsdóttir S
Virus Res; 1998 Feb; 53(2):107-20. PubMed ID: 9620203
[TBL] [Abstract][Full Text] [Related]
59. Characterization of a novel baboon virus closely resembling human T-cell leukemia virus.
Vincent MJ; Novembre FJ; Yamshchikov VF; McClure HM; Compans RW
Virology; 1996 Dec; 226(1):57-65. PubMed ID: 8941322
[TBL] [Abstract][Full Text] [Related]
60. Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus.
Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
Biochem Biophys Res Commun; 2001 Nov; 289(1):1-6. PubMed ID: 11708767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
